Diagnostics impact every part of a pandemic from testing of the first case and upscale during outbreaks to confirmation of elimination and surveillance. Dr Adams will talk about her work in diagnostic discovery, development and evaluation in pandemic related disease. She will highlight the challenges of getting tests to market and the value of partnerships.

Dr. Emily Adams recently joined PSI as a Principal Investigator and is also the Chief of Global Health at GADx, a UK-based social enterprise focused on diagnostics. She leads the global health portfolio, strategy, and business development activities at GADx. Emily combines academic research and industry expertise to bring high-potential diagnostic tests to market and maximize their impact.

The seminar will take place from 12:30 to 13:30 in the BDI building, seminar rooms, followed by lunch and networking from 13:30 to 14:30.